Navigation Links
Despite Economic Turmoil, CIS Named to Inc. 5000 List of Fastest-Growing Private Companies in America
Date:9/9/2010

PHILADELPHIA, Sept. 9 /PRNewswire/ -- Compliance Implementation Services (CIS), a pharmaceutical compliance consulting firm, announced today that it has been named to Inc. Magazine's fourth annual Top 5000 list of fastest-growing privately held companies in the United States.

(Logo:  http://photos.prnewswire.com/prnh/20100817/INC5000LOGO)

(Logo:  http://www.newscom.com/cgi-bin/prnh/20100817/INC5000LOGO)

"The leaders of the companies on this year's Inc. 5000 have figured out how to grow their businesses during the longest recession since the Great Depression," said Inc. president Bob LaPointe. "The 2010 Inc. 5000 showcases a particularly hardy group of entrepreneurs."

CIS ranked # 1541, the top third of the Inc. 5000 list, and #36 of the top companies in the Philadelphia metro area. Founded in 2004 by entrepreneurs Jim Collins and Toni Barsh, the firm has achieved a 188% three-year revenue growth while assisting some of the pharmaceutical industry's "Who's Who" of companies with their compliance needs.  

About CIS

Compliance Implementation Services (CIS) is a consulting firm specializing in compliance strategies for the pharmaceutical industry, from Global Clinical Research and Development, through Manufacturing, U.S. Commercial Compliance, and Government Programs. Founded in 2004, CIS provides its clients with a deep understanding of industry laws and regulations, innovative and practical applications, and custom solutions to establish a "Culture of Compliance" that is both meaningful and sustainable. CIS experts identify, assess and prioritize an organization's exposure to compliance risks, subsequently developing and implementing risk evaluation and mitigation techniques to ensure adherence to legal and regulatory requirements. For more information, visit www.cis-partners.com.

About Inc. Magazine Top 5000 List

In 2007, the Inc. 500 list expanded to the Inc. 500|5000, giving readers a deeper, richer understanding of the entrepreneurial landscape and capturing a broader spectrum of success. The Inc. 500|5000 ranks companies by overall revenue growth over a three-year period and is a celebration of innovation among American entrepreneurial leaders. Complete results of the Inc. 5000, including company profiles and an interactive database that can be sorted by industry, region, and other criteria, can be found on www.inc.com/5000.


'/>"/>
SOURCE Compliance Implementation Services
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Influenza is Leading Cause of Vaccine-Preventable Deaths for Kids; Despite CDC Recommendations, Moms Still Dont Vaccinate
2. Despite Serious Health Risks, One in Three Adults with Heart Disease Does Not Believe They Need a Flu Shot This Year
3. Organ Donor Shortage Remains Obstacle for Would-Be Transplant Patients Despite Better Medicine
4. Study Finds PCI Safe, Effective Despite Off-Site Cardiac Surgery
5. Intermezzo(R) 3.5 mg Achieves Greater Early Bioavailability Than Ambien(R) 10 mg Despite 65% Lower Dose
6. Despite Advances in the Accuracy of CT Colonography in Detecting Polyps, Digestive Health Experts Urge Patients to Consider Risks and Realities
7. New International Study Shows Women With Symptomatic Fibroids Delaying Treatment Despite Substantial Burden on Quality of Life
8. R&D Spending by U.S. Biopharmaceutical Companies Reaches Record Levels in 2008 Despite Economic Challenges
9. Plasma Products Safe Despite Swine Influenza Outbreak, Assures International Biopharmaceutical Company Octapharma
10. Despite Limited Capital Equipment Purchases In 2009, The Global Powered Surgical Instrument Market Held Its Value At $800 Million
11. Despite Recessionary Pressures, Patient and Surgeon Demand Will Drive the Joint Arthroplasty and Fixation Bone Cement Market by 7% Annually Through 2013
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/31/2016)... May 31, 2016   Plexus Technology Group, ... anesthesia information management systems (AIMS), is pleased to ... as Vice President of Technology. In this new ... aspects of the company,s technological development. He will ... to determine the expansion of new products, product ...
(Date:5/31/2016)... , May 31, 2016 ... market is progressing at a CAGR of 10.6% within ... was valued at US$0.46 bn in 2013. Owing to ... expected to reach US$0.88 bn by the end of ... derived from the market,s holistic representation in a research ...
(Date:5/31/2016)... , May 31, 2016 ... the initiation of a first-in-human clinical trial of its ... molecule - S101 is currently being developed for the ... study is designed to evaluate the safety and tolerability ... at several sites across the United States ...
Breaking Medicine Technology:
(Date:5/31/2016)... Atlanta, GA (PRWEB) , ... May 31, 2016 ... ... Contact Center Solutions , today announced it has been included by Gartner, ... 2016 report mentions a wide range of Contact Center Infrastructure technologies, some of ...
(Date:5/31/2016)... ... May 31, 2016 , ... Splashtop Inc., the worldwide leader ... with e-Jan Networks Co., the leading provider of secure mobile remote access solution ... Networks’s leading CACHATTO remote access solution. Splashtop for CACHATTO will be ...
(Date:5/31/2016)... ... May 31, 2016 , ... St. Joseph Medical Center (SJMC) ... exchange, which enables physicians at SJMC’s two hospital campuses, downtown and in the ... in the exchange. SJMC’s membership in the health information exchange underscores the hospital’s ...
(Date:5/31/2016)... , ... May 31, 2016 , ... Twenty years ago ... experience, rather than trying to silence the voices they hear. But this approach has ... itself. , The method has steadily gained credibility and now is used around the ...
(Date:5/31/2016)... ... 31, 2016 , ... The University of Tennessee Medical Center ... the latest in Clinical Patient Pod (CPP) technologies provided through Jvion’s ... into the clinical workflow. These insights are empowering the more than 30 case ...
Breaking Medicine News(10 mins):